Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Prostatic Neoplasms 185Breast Neoplasms 27Neoplasms 13Leiomyoma 11Polycystic Ovary Syndrome 5Neoplasm Metastasis 4Salivary Gland Neoplasms 3Prostate Adenocarcinoma 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Adenocarcinoma 3Rare Diseases 2Premenopausal Breast Cancer 2Myofibroma 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Breast Neoplasms, Male 2Uveal Melanoma 1Uterine Neoplasms 1Urogenital Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasm Duct 1Respiratory Tract Diseases 1Recurrence 1

Interventions

Robotic Surgical Procedures 2Urine Specimen Collection 1Surveys and Questionnaires 1Stents 1Metformin 1Mammography 1Leuprolide 1Laparoscopy 1Interviews as Topic 1Hepatectomy 1Blood Specimen Collection 1Biopsy 1Bariatric Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Obesity, Morbid × Leuprolide × Clear all
NCT04331717 2022-05-02

BASH-PC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn
Other

Obesity, Morbid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡